estradiol valerate / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 18 Diseases   24 Trials   24 Trials   720 News 


«123456789»
  • ||||||||||  estradiol valerate / Generic mfg.
    Journal:  Genetic analysis of novel pathogenic gene HROB in primary ovarian insufficiency. (Pubmed Central) -  Dec 18, 2023   
    Whole exome sequencing and Sanger sequencing confirmed that the proband and her sister carried heterozygous variants of HROB gene c.718C>T (p.Arg240*) and c.1351C>T (p.Arg451*), which were inherited from their parents respectively and consistent with autosomal recessive inheritance. Oral estradiol valerate at an initial dose of 0.125 mg/d was given to the proband, and the secondary sexual characteristics and uterine development were monitored.
  • ||||||||||  Menopur (menotropin) / Ferring, NN1213 / Novo Nordisk
    Enrollment open, Trial completion date, Trial primary completion date:  HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) -  Oct 30, 2023   
    P4,  N=150, Recruiting, 
    ChiCTR2300073146. Unknown status --> Recruiting | Trial completion date: Mar 2021 --> Dec 2024 | Trial primary completion date: Jan 2021 --> Dec 2024
  • ||||||||||  estradiol valerate / Generic mfg.
    Preclinical, Journal:  Evaluation of renal disturbance in animal models of polycystic ovary syndrome. (Pubmed Central) -  Sep 17, 2023   
    According to statistical analysis it indicated that induction of TP and EV can increase blood uric acid levels in PCOS model rats (p 0.05). Based on the results of this study, it can be concluded that the induction of animal models with TP can trigger significant renal damage compared to EV.
  • ||||||||||  Utrogestan (progesterone) / Besins Healthcare
    Trial completion date, Trial primary completion date:  Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients (clinicaltrials.gov) -  Sep 14, 2023   
    P4,  N=522, Recruiting, 
    Based on the results of this study, it can be concluded that the induction of animal models with TP can trigger significant renal damage compared to EV. Trial completion date: Oct 2022 --> Dec 2025 | Trial primary completion date: Jun 2021 --> Sep 2025
  • ||||||||||  prednisone / Generic mfg., estradiol valerate / Generic mfg.
    Journal:  Congenital adrenal hyperplasia disorder due to 17 ?-hydroxylase deficiency: a case report. (Pubmed Central) -  Sep 13, 2023   
    There is no significant change in large adrenal hyperplasia lesions although sexual characteristics and menstrual cycles have recovered. Through this case and literature review, it can be concluded that CAH with 17?-OHD can be diagnosed according to the genetic detection.
  • ||||||||||  estradiol valerate / Generic mfg.
    Preclinical, Journal:  Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model. (Pubmed Central) -  Aug 21, 2023   
    In this study, C57BL/6 female mice were ovariectomized and supplemented with estradiol valerate (OVX + E2) to eliminate the effect of the hypothalamic-pituitary-gonadal axis...The OVF model has the advantages of being stable, low cost, and easy to operate, which is suitable for studies to explore the extragonadal actions of FSH. Here, we describe detailed protocols for the mouse OVF model.
  • ||||||||||  estradiol valerate / Generic mfg.
    Journal:  Reactive Paper Spray Ionization Mass Spectrometry for Rapid Detection of Estrogens in Cosmetics. (Pubmed Central) -  Aug 12, 2023   
    Using estradiol valerate as the internal standard (I.S.), three estrogens, estradiol, estriol, and ethinyloestradiol, in cosmetics were quantitatively characterized within minutes...Compared to conventional paper spray ionization mass spectrometry (PSI-MS), extraction is not required and the detection sensitivity of RPSI-MS was improved by 34,000, 80,000, and 1400 times for estradiol, estriol, and ethinyloestradiol, respectively. The protocol established in this paper is sensitive, eco-friendly, and suitable for rapid testing of estrogens in cosmetics.
  • ||||||||||  progesterone / Generic mfg., metformin / Generic mfg., estradiol valerate / Generic mfg.
    Preclinical, Journal:  Chemical Characterization and Ameliorating Effect of Centratherum anthelminticum Extract against Polycystic Ovary Syndrome in Wistar Rats. (Pubmed Central) -  Jul 24, 2023   
    After the induction of PCOS, oral metformin (300?mg/kg) was given to the standard group, while CA was orally administered to diseased rats at 250, 500, and 750?mg/kg/day for 28?days...A significant rise was observed in progesterone and follicle stimulating hormone with a decrease in luteinizing hormone in the treatment groups as compared to disease control, which indicated normalization of the estrus cycle...Histopathological examination showed the different developmental stages of normal follicles in CA-treated diseased rats which were indicative of a normal fertile estrous cycle. Overall, the results confirmed the efficacy of CA against PCOS in treating estradiol-HFD-induced PCOS due to its antidiabetic, anti-inflammatory, antihyperlipidemic, and antioxidant properties.
  • ||||||||||  amitriptyline / Generic mfg., estradiol valerate / Generic mfg.
    Journal:  An investigation of the potential effects of amitriptyline on polycystic ovary syndrome induced by estradiol valerate. (Pubmed Central) -  Jul 3, 2023   
    In addition, this study is one of the few studies examining the effects of amitriptyline, an antidepressant frequently used in depression treatment of individuals with PCOS. We also observed firstly that use of amitriptyline caused PCOS-like ovarian morphology in healthy rat ovaries, while it had a healing effect by volume decreasing of cystic structures in the ovary with PCOS.
  • ||||||||||  estradiol valerate / Generic mfg.
    Review, Journal:  Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. (Pubmed Central) -  May 19, 2023   
    No studies reported indication for hormonal contraceptive use, which is important as individuals who use hormonal management for medical conditions like heavy menstrual bleeding might have different risk profiles compared to individuals using hormones for contraception. Future studies should focus on including pertinent confounders like age, obesity, history of prior venous thromboembolism, risk factors for venous thromboembolism, and recent pregnancy.
  • ||||||||||  leuprolide acetate for depot suspension / Generic mfg., estradiol valerate / Generic mfg.
    Hematospermia in Transgender Woman Revealing Occult Endometriosis (ENDOExpo) -  May 11, 2023 - Abstract #ENDO2023ENDO_2457;    
    The incidence and prevalence of hematospermia in transgender women is unknown.Clinical Course: A 35-year-old transgender woman treated with estradiol valerate and leuprolide presents with persistent hematospermia and two years of intermittent hematuria. Hematospermia in transgender women on GAHT** may indicate occult M
  • ||||||||||  estradiol valerate / Generic mfg.
    Journal:  Rapid Detection of Estrogens in Cosmetics by Chemical Derivatization and Paper-Spray Ionization Mass-Spectrometry. (Pubmed Central) -  Feb 12, 2023   
    EPA in the used doses provided biochemical and histopathological improvement in EV-induced EH via modulation of NF-?B/HIF-1?/VEGF signaling pathway. Since most estrogens show poor responses in PSI-MS, we developed a chemical derivatization and PSI-MS method to determinate three estrogens: estradiol, estriol and ethinyloestradiol with estradiol valerate as the internal standard (I.S.)...The limits of detection (LOD) were 0.04 ?g
  • ||||||||||  progesterone / Generic mfg., estradiol valerate / Generic mfg.
    Trial initiation date:  Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle. (clinicaltrials.gov) -  Feb 2, 2023   
    P=N/A,  N=40, Not yet recruiting, 
    Since most estrogens show poor responses in PSI-MS, we developed a chemical derivatization and PSI-MS method to determinate three estrogens: estradiol, estriol and ethinyloestradiol with estradiol valerate as the internal standard (I.S.)...The limits of detection (LOD) were 0.04 ?g Initiation date: Nov 2022 --> Mar 2023
  • ||||||||||  chlorogenic acid / Jiuzhang Biotech
    Preclinical, Journal:  Effect of chlorogenic acid on follicular development, hormonal status and biomarkers of oxidative stress in rats with polycystic ovary syndrome. (Pubmed Central) -  Jan 24, 2023   
    The serum level of luteinizing hormone, estrogen, testosterone, antioxidant capacity, glutathione and the number of cystic follicles in the PCOS group treated with 100 mg kg Chlorogenic acid compared to the non-treated PCOS group were significantly decreased, however, the serum level of follicle stimulating hormone, progesterone, MDA and the number of secondary, graafian follicles and corpus luteum were significantly increased. Chlorogenic acid could be effective in ameliorating follicular development as well as hormonal and biochemical disorders in rats with PCOS.
  • ||||||||||  estradiol valerate / Generic mfg.
    Trial completion date, Trial primary completion date:  Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors (clinicaltrials.gov) -  Jan 17, 2023   
    P=N/A,  N=4, Active, not recruiting, 
    Chlorogenic acid could be effective in ameliorating follicular development as well as hormonal and biochemical disorders in rats with PCOS. Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Dec 2022 --> Dec 2023
  • ||||||||||  estradiol valerate / Generic mfg.
    Review, Journal:  Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception. (Pubmed Central) -  Jan 10, 2023   
    No studies reported indication for hormonal contraceptive use, which is important as individuals who use hormonal management for medical conditions like heavy menstrual bleeding might have different risk profiles compared to individuals using hormones for contraception. Future studies should focus on including pertinent confounders like age, obesity, history of prior venous thromboembolism, risk factors for venous thromboembolism, and recent pregnancy.
  • ||||||||||  progesterone / Generic mfg., dydrogesterone / Generic mfg.
    Journal:  The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels. (Pubmed Central) -  Nov 30, 2022   
    CZ-derived AgNPs may have an anti-inflammatory effect in PCOS rats by decreasing the concentrations of inflammatory cytokines TNF-α, IL-6 and IL-18.  Our results indicate that DYD 10 mg three times a day administered in women who perform FET with P4 serum levels < 10 ng/mL, allows this group to have pregnancy rates beyond 12 weeks at least as good as those with serum levels above 10 ng/mL.
  • ||||||||||  progesterone / Generic mfg., estradiol valerate / Generic mfg.
    Journal:  Effects of different doses of estrogen on ER expression and ovarian function in patients with unexplained recurrent abortion. (Pubmed Central) -  Nov 15, 2022   
    The higher the therapeutic dose of estrogen, the stronger the inhibition of ovarian ovulation, and the standard dose of estrogen has obvious advantages in increasing the expression of ER in intima. Limitation: 1) Insufficient sample size; 2) We need to increase the sampling time point to further observe the difference of estrogen in time effect, so as to obtain a more accurate action time of estrogen; 3) The longer-term effects of different doses of estrogen on intima were not studied, such as whether there are adverse pregnancy outcomes such as preterm birth, placental implantation, or premature exfoliation.
  • ||||||||||  progesterone / Generic mfg., estradiol valerate / Generic mfg.
    Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date:  Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle. (clinicaltrials.gov) -  Nov 15, 2022   
    P=N/A,  N=40, Recruiting, 
    Limitation: 1) Insufficient sample size; 2) We need to increase the sampling time point to further observe the difference of estrogen in time effect, so as to obtain a more accurate action time of estrogen; 3) The longer-term effects of different doses of estrogen on intima were not studied, such as whether there are adverse pregnancy outcomes such as preterm birth, placental implantation, or premature exfoliation. Not yet recruiting --> Recruiting | Trial completion date: Sep 2023 --> Dec 2023 | Initiation date: Aug 2022 --> Nov 2022 | Trial primary completion date: Aug 2023 --> Nov 2023
  • ||||||||||  estradiol valerate / Generic mfg.
    Preclinical, Journal, IO biomarker:  Therapeutic potentials of the caffeine in polycystic ovary syndrome in a rat model: Via modulation of proinflammatory cytokines and antioxidant activity. (Pubmed Central) -  Nov 13, 2022   
    For this purpose, 40 female rats were divided into five groups: (1) control group (without any intervention), (2) sham group (administration of olive oil as a caffeine solvent), (3) PCOS group (injection of 2 mg of estradiol valerate for each rat), (4) caffeine group (administration of 37.5 mg/kg caffeine for each rat), and (5) PCOS + caffeine group...On the other hand, the expression of IL-6 and TNF-α in PCOS + caffeine group was high compared to other groups. We found that caffeine can reduce apoptosis and inflammation in PCOS ovaries and enhance the unpleasant symptoms of PCOS.
  • ||||||||||  estradiol valerate / Generic mfg.
    Journal:  Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling. (Pubmed Central) -  Oct 18, 2022   
    After 14 days of primary immunization, rats were administered YSJB or estradiol valerate (EV) for 28 days...YSJB treatment reduced NFATc1 expression significantly but also increased ephrinB2 expression in the BM markedly. These data suggest that YSJB exhibit a bone-protective effect, it may be a promising therapeutic strategy for alleviating bone destruction in arthritis under postmenopausal conditions, and one of the mechanisms is associated with the modulation of ephrinB2 signaling.
  • ||||||||||  estradiol valerate / Generic mfg.
    Preclinical, Journal:  Jin-Tian-Ge ameliorates ovariectomy-induced bone loss in rats and modulates osteoblastogenesis and osteoclastogenesis in vitro. (Pubmed Central) -  Oct 6, 2022   
    These data suggest that YSJB exhibit a bone-protective effect, it may be a promising therapeutic strategy for alleviating bone destruction in arthritis under postmenopausal conditions, and one of the mechanisms is associated with the modulation of ephrinB2 signaling. JTG prevented bone loss in OVX rats and increased osteogenic differentiation of BMSCs through regulation of the BMP and Wnt/β-catenin pathway, inhibited osteoclastogenesis by suppressing the NF-κB pathway, suggesting that JTG had the potentials for prevention and treatment of osteoporosis by modulating formation and differentiation of osteoblast and osteoclast.
  • ||||||||||  progesterone / Generic mfg., estradiol valerate / Generic mfg.
    Preclinical, Journal:  Long Term Oral Administration of Oregano Essence Effectively Relieves Polycystic Ovarian Rats through Endocrine and Inflammatory Balance. (Pubmed Central) -  Sep 29, 2022   
    Overall, in the disrupted PCOS rats, OE oral treatment effectively relieved estradiol-induced PCOS rats via: (1) its endocrine balancing on GnRH, FSH, and LH and (2) its anti-inflammatory and antioxidant properties on ovary caused by OE's useful compounds like pulegone, thymol, and L-menthone. Though many aspects of the effects remain to be tested, such an underlying mechanistic reproductive regulatory effect observed in OE-administered rats further proves its sensible pharmaceutical applications in reproductive medicine and more specifically, PCOS.